Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Unknown 5Completed 5Recruiting 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Polycystic Ovary Syndrome 8Neoplasms 3Melanoma 3Infertility 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Ovarian Neoplasms 2Obesity 2Metabolic Diseases 2Insulin Resistance 2Glioblastoma 2Endometrial Neoplasms 2Breast Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1TP53 Y220C Mutation 1Sarcoma, Ewing 1Sarcoma 1Prostate Cancer Recurrent 1Progression-Free Survival 1Preleukemia 1Posterior Fossa Ependymal Tumor 1Osteosarcoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms by Site 1Medulloblastoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Hyperandrogenism 1

Interventions

pembrolizumab 38Blood Specimen Collection 38Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 17Exercise 17Carboplatin 17Nivolumab 15atezolizumab 14Paclitaxel 14Cisplatin 14Drug Therapy 13Fluorouracil 12Cyclophosphamide 12Cetuximab 11Trastuzumab 10Pemetrexed 10Leucovorin 10Docetaxel 10Dexamethasone 10Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × Metformin × Clear all
NCT05768139 2026-05-22

PIKALO-1

Eli Lilly and Company

Phase 1/2 Recruiting
880 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT05515978 2025-12-04

PragMet

University of Colorado, Denver

Phase EARLY_PHASE1 Recruiting
100 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT05929495 2025-07-25

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

University of Milano Bicocca

Phase 2 Recruiting
25 enrolled
CNS

Glioblastoma, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡